Table 1 Overview of screens per phase per site
From: Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer
Site | First month | Final month | Vendor | Equipment model | No. of available double-read screens | No. of processed screens | Percentage |
|---|---|---|---|---|---|---|---|
Phase 1, initial pilot (1 site, 1 additional arbitrator, additional arbitration cases were single read) | |||||||
Site 1 | April 2021 | September 2021 | IMS | Giotto Class | 3,817 | 3,746 | 98.1% |
Phase 2, extended pilot (4 sites, 3 additional arbitrators, all additional arbitration cases were read by each additional arbitrator) | |||||||
Site 1 | April 2021 | December 2021 | IMS | Giotto Class | 5,859 | 5,758 | 98.3% |
Site 2 | April 2021 | June 2021 | IMS | Giotto Class | 1,187 | 1,172 | 98.7% |
Site 3 | April 2021 | June 2021 | IMS | Giotto Image 3DL | 918 | 911 | 99.2% |
Site 4 | April 2021 | June 2021 | IMS | Giotto Image 3DL | 1,302 | 1,271 | 97.6% |
Total | 9,266 | 9,112 | 98.3% | ||||
Phase 3, live use in standard clinical practice (4 sites, 3 additional arbitrators, additional arbitration cases were single read) | |||||||
Site 1 | July 2022 | January 2023 | IMS | Giotto Class | 4,818 | 4,711 | 97.8% |
Site 2 | July 2022 | January 2023 | IMS | Giotto Class | 4,605 | 4,537 | 98.5% |
Site 3 | July 2022 | January 2023 | IMS | Giotto Image 3DL | 2,925 | 2,903 | 99.2% |
Site 4 | July 2022 | January 2023 | IMS | Giotto Image 3DL | 3,908 | 3,802 | 97.3% |
Total | 16,256 | 15,953 | 98.1% | ||||
